Nucleic Acid Based Therapeutics Market Share

Statistics for the 2023 & 2024 Nucleic Acid Based Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Nucleic Acid Based Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Nucleic Acid Based Therapeutics Industry

The nucleic acid-based therapeutics market is moderately fragmented due to the presence of many small and large players globally and regionally. The companies are engaging in the research and development of nucleic acid-based therapeutics for the treatment of various chronic, genetic, and infectious diseases. Some of the key companies in the market are Silence Therapeutics PLC, Ionis Pharmaceuticals Inc., Sarepta Therapeutics, Novartis Pharma AG, Alnylam Pharmaceuticals Inc., and Biogen Inc., among others.

Nucleic Acid-Based Therapeutics Market Leaders

  1. Silence Therapeutics plc

  2. Ionis Pharmaceuticals, Inc.

  3. Novartis Pharma AG

  4. Sarepta Therapeutics, Inc.

  5. Alnylam Pharmaceuticals, Inc.

*Disclaimer: Major Players sorted in no particular order

Nucleic Acid Based Therapeutics Market Concentration

Nucleic Acid-Based Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)